| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |